Intermittent and directly observed chemotherapy: The sensible therapeutic option in the treatment of tuberculosis

D. Wilkinson*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

1 Citation (Scopus)

Abstract

Intermittent chemotherapy for tuberculosis-treatment given two or three times each week-is as effective as treatment given every day. Specifically, treatment given three times each week (without a phase of daily therapy) is as effective as treatment given daily. If treatment is given twice weekly, cure rates are equivalent to those achieved when a daily phase is given, and recent evidence suggests that a daily phase is not necessary. Directly observed therapy has been shown to be a highly effective strategy in resource-poor settings and by achieving high completion rates. In combination, directly observed, and intermittent therapy is shown to be highly cost-effective. In the HIV era, with a much increased tuberculosis case-load, hospitalization for 2 months to ensure adherence may no longer be possible. Intermittent and directly observed chemotherapy is indeed the sensible therapeutic option in the treatment of tuberculosis, especially when treatment is delivered in the community in resource-poor settings.

Original languageEnglish
Pages (from-to)97-105
Number of pages9
JournalBailliere's Clinical Infectious Diseases
Volume4
Issue number1
Publication statusPublished - 1997
Externally publishedYes

Keywords

  • Adherence
  • Directly observed therapy
  • Intermittent chemotherapy
  • Tuberculosis

Fingerprint

Dive into the research topics of 'Intermittent and directly observed chemotherapy: The sensible therapeutic option in the treatment of tuberculosis'. Together they form a unique fingerprint.

Cite this